Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $862,958 - $1.14 Million
-8,415 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$63.89 - $73.8 $537,634 - $621,027
8,415 New
8,415 $588,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track One68 Global Capital, LLC Portfolio

Follow One68 Global Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One68 Global Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on One68 Global Capital, LLC with notifications on news.